Inner Mongolia Furui Medical Science Co., Ltd.

SZSE:300049 Stock Report

Market Cap: CN¥11.3b

Inner Mongolia Furui Medical Science Future Growth

Future criteria checks 5/6

Inner Mongolia Furui Medical Science is forecast to grow earnings and revenue by 37.7% and 22.9% per annum respectively. EPS is expected to grow by 38% per annum. Return on equity is forecast to be 16.4% in 3 years.

Key information

37.7%

Earnings growth rate

37.99%

EPS growth rate

Pharmaceuticals earnings growth18.0%
Revenue growth rate22.9%
Future return on equity16.40%
Analyst coverage

Low

Last updated08 May 2026

Recent future growth updates

Recent updates

Analysis Article • Mar 12

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) P/E Is On The Mark

With a price-to-earnings (or "P/E") ratio of 72.7x Inner Mongolia Furui Medical Science Co., Ltd. ( SZSE:300049 ) may...
Analysis Article • Dec 18

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Analysis Article • Oct 17

Subdued Growth No Barrier To Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049) With Shares Advancing 35%

Inner Mongolia Furui Medical Science Co., Ltd. ( SZSE:300049 ) shareholders would be excited to see that the share...
Analysis Article • Sep 02

Here's Why We Think Inner Mongolia Furui Medical Science (SZSE:300049) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analysis Article • Jul 21

Inner Mongolia Furui Medical Science Co., Ltd.'s (SZSE:300049) Intrinsic Value Is Potentially 30% Above Its Share Price

Key Insights Inner Mongolia Furui Medical Science's estimated fair value is CN¥62.65 based on 2 Stage Free Cash Flow to...
Analysis Article • May 24

With EPS Growth And More, Inner Mongolia Furui Medical Science (SZSE:300049) Makes An Interesting Case

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
Analysis Article • Apr 29

We Think Inner Mongolia Furui Medical Science (SZSE:300049) Can Manage Its Debt With Ease

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Feb 28

Investors Still Waiting For A Pull Back In Inner Mongolia Furui Medical Science Co., Ltd. (SZSE:300049)

Inner Mongolia Furui Medical Science Co., Ltd.'s ( SZSE:300049 ) price-to-sales (or "P/S") ratio of 10.5x may look like...

Earnings and Revenue Growth Forecasts

SZSE:300049 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,196520N/A8741
12/31/20272,4253792585422
12/31/20262,0452862003021
3/31/20261,625157185368N/A
12/31/20251,595154163352N/A
9/30/20251,47012399313N/A
6/30/20251,4209010251N/A
3/31/20251,3579922258N/A
12/31/20241,3491132221N/A
9/30/20241,32713031225N/A
6/30/20241,27213385289N/A
3/31/20241,23413190273N/A
12/31/20231,154102116305N/A
9/30/20231,09711099282N/A
6/30/20231,084109148268N/A
3/31/20231,042102109223N/A
1/1/20231,0099899189N/A
9/30/20221,01798120197N/A
6/30/20229608690174N/A
3/31/202293192134221N/A
1/1/202289895143223N/A
9/30/202184890125220N/A
6/30/20218328983201N/A
3/31/20217806460169N/A
12/31/20208086290200N/A
9/30/20208175079171N/A
6/30/202080842144210N/A
3/31/202086247213278N/A
12/31/201983243N/A256N/A
9/30/20198581N/A269N/A
6/30/20198653N/A178N/A
3/31/201986632N/A122N/A
12/31/201886735N/A78N/A
9/30/201882471N/A84N/A
6/30/201879970N/A138N/A
3/31/201884463N/A138N/A
12/31/201782361N/A132N/A
9/30/2017882117N/A106N/A
6/30/2017886117N/A109N/A
3/31/2017858121N/A114N/A
12/31/2016827121N/A149N/A
9/30/2016709100N/A189N/A
6/30/201667199N/A143N/A
3/31/201660892N/A167N/A
12/31/201560492N/A158N/A
9/30/201564990N/A101N/A
6/30/2015668108N/A127N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 300049's forecast earnings growth (37.7% per year) is above the savings rate (2.4%).

Earnings vs Market: 300049's earnings (37.7% per year) are forecast to grow faster than the CN market (26.7% per year).

High Growth Earnings: 300049's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 300049's revenue (22.9% per year) is forecast to grow faster than the CN market (16.3% per year).

High Growth Revenue: 300049's revenue (22.9% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 300049's Return on Equity is forecast to be low in 3 years time (16.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/15 16:42
End of Day Share Price 2026/06/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Inner Mongolia Furui Medical Science Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhu ChenCitic Securities Co., Ltd.
Yiling ChenGuosen Securities Co., Ltd.
Xibing ChenGuosen Securities Co., Ltd.